Syra Health Free Cash Flow (FCF) History (SYRA)
Syra Health reported −$447,853 in free cash flow for fiscal 2025, an increase of $2.5M from the previous fiscal year, with a free cash flow margin of −6.20%.
View full Syra Health company overviewSyra Health free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | −$447,853 | $2.5M | — | −6.20% |
| 2024 | 2024-12-31 | −$2.9M | −$168,825 | — | −36.87% |
| 2023 | 2023-12-31 | −$2.8M | −$408,994 | — | −50.30% |
| 2022 | 2022-12-31 | −$2.4M | — | — | −42.10% |
Syra Health quarterly free cash flow
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q4 2024 | 2024-12-31 | −$214,720 | $1.5M | — | −10.70% |
| Q3 2024 | 2024-09-30 | −$413,301 | −$44,038 | — | −18.34% |
| Q2 2024 | 2024-06-30 | −$1.5M | −$915,466 | — | −76.60% |
| Q1 2024 | 2024-03-31 | −$806,364 | −$751,643 | — | −46.02% |
| Q4 2023 | 2023-12-31 | −$1.8M | — | — | −99.48% |
| Q3 2023 | 2023-09-30 | −$369,263 | — | — | −23.35% |
| Q2 2023 | 2023-06-30 | −$593,293 | — | — | −60.59% |
| Q1 2023 | 2023-03-31 | −$54,721 | — | — | −4.60% |
Syra Health free cash flow growth trends
Syra Health's latest reported quarter, Q4 2024, generated −$214,720 in free cash flow, an increase of $1.5M year over year.
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
How free cash flow is calculated
TickerStat calculates free cash flow as reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Syra Health source filings ↗